Patient-derived xenograft (PDX) models, applications and challenges in cancer research

The establishing of the first cancer models created a new perspective on the identification and evaluation of new anti-cancer therapies in preclinical studies. Patient-derived xenograft models are created by tumor tissue engraftment. These models accurately represent the biology and heterogeneity of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of translational medicine Ročník 20; číslo 1; s. 206 - 15
Hlavní autoři: Abdolahi, Shahrokh, Ghazvinian, Zeinab, Muhammadnejad, Samad, Saleh, Mahshid, Asadzadeh Aghdaei, Hamid, Baghaei, Kaveh
Médium: Journal Article
Jazyk:angličtina
Vydáno: London BioMed Central 10.05.2022
BioMed Central Ltd
Springer Nature B.V
BMC
Témata:
Animal models in research
Animals
Antitumor agents
Avatar model of cancer
Biomedical and Life Sciences
Biomedicine
Cancer
Cancer animal model
Cancer microenvironment
Cancer research
Cancer therapies
Chemotherapy
Clinical trials
COVID-19
Disease Models, Animal
Drug development
Drugs
Gene expression
Heterografts
Humanized model
Humans
Immune system
Immunotherapy
Medical research
Medicine/Public Health
Neoplasms - pathology
Patient outcomes
Patients
PDX
Precision medicine
Precision Medicine - methods
Preclinical study
Prevention
Review
Success
Transplants & implants
Tumor Microenvironment
Tumors
Validity
Xenograft Model Antitumor Assays
Xenografts
Xenotransplantation
United States
Preclinical study
Humanized model
PDX
Cancer animal model
Avatar model of cancer
ISSN:1479-5876, 1479-5876
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The establishing of the first cancer models created a new perspective on the identification and evaluation of new anti-cancer therapies in preclinical studies. Patient-derived xenograft models are created by tumor tissue engraftment. These models accurately represent the biology and heterogeneity of different cancers and recapitulate tumor microenvironment. These features have made it a reliable model along with the development of humanized models. Therefore, they are used in many studies, such as the development of anti-cancer drugs, co-clinical trials, personalized medicine, immunotherapy, and PDX biobanks. This review summarizes patient-derived xenograft models development procedures, drug development applications in various cancers, challenges and limitations.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:1479-5876
1479-5876
DOI:10.1186/s12967-022-03405-8